2.2. Setting and participants
AMD, cardiovascular disease, comorbid severe primary diseases, vision-affected ocular diseases, allergy, mydriasis, glaucoma
CARDIOVASCULAR DISEASE, ALLERGY, RETINA, GLAUCOMA, DISEASES OF THE LIVER, DISEASES, CEREBROVASCULAR DISEASE
Patients were recruited from the Tokyo Medical and Dental University Hospital. The inclusion criteria were as follows: Japanese origin, AL of eyeball 26.5 mm or more, and less than 30.0 mm; age 20 to 50 years, and patient consent. The exclusion criteria were as follows: comorbid severe primary diseases, such as cardiovascular disease, cerebrovascular disease, and diseases of the liver, kidneys, or hematopoietic system; pupil diameter less than 6.5 mm in mydriasis; vision-affected ocular diseases, such as glaucoma, AMD, and diseases of the retina; administration of lutein within the last 6 months; allergy to multiple drugs or known allergy to lutein capsule components; and other conditions considered unsuitable for participation after discussion.